Matthew O'Brien
Stock Analyst at Piper Sandler
(0.39)
# 4,514
Out of 5,116 analysts
1295
Total ratings
42.4%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Reiterated: Hold | $4 → $1.5 | $0.8687 | +72.67% | 26 | Nov 6, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $100 | $71.05 | +40.75% | 57 | Nov 6, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $25 | $20.54 | +21.71% | 7 | Nov 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $100 | $88.24 | +13.33% | 44 | Nov 6, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $33 | $16.91 | +95.15% | 36 | Nov 6, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $3.5 → $12 | $10.08 | +19.05% | 25 | Nov 5, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $60 → $70 | $58.54 | +19.58% | 44 | Nov 4, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $25 | $24.24 | +3.14% | 8 | Nov 3, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $14 | $7.44 | +88.17% | 39 | Oct 30, 2026 | |
| DXCM DexCom | Reiterated: Buy | $95 | $79.41 | +19.63% | 68 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $325 | $325.87 | -0.27% | 55 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 | $51.50 | -12.62% | 43 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $24 | $15.70 | +52.87% | 13 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $30 | $31.76 | -5.54% | 31 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $101.80 | -16.50% | 65 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $64 | $52.40 | +22.14% | 6 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $5.68 | +111.27% | 11 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $60 | $42.75 | +40.35% | 62 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $28.80 | +4.17% | 9 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.82 | +21.95% | 27 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $14.52 | +23.97% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $20.62 | +21.24% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $97 → $127 | $126.56 | +0.35% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $146.51 | +43.33% | 38 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $16.71 | -4.25% | 2 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0649 | +4,522.50% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $319.21 | +17.16% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $105.59 | n/a | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $25.21 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $150.87 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $11 | $16.59 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $180 | $224.41 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $2.93 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $0.4482 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $44 | $13.42 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $0.8374 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $90 | $0.0002 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $2.15 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $25.79 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $79 | $87.23 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $26.03 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $3.09 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $435 | $62.36 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $89.99 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $258 → $345 | $166.00 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 → $633 | $452.80 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $5.81 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.31 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $6.03 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $9.46 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $235.30 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.2894 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.04 | n/a | 2 | May 8, 2012 |
CVRx, Inc.
Nov 6, 2026
Reiterated: Hold
Price Target: $4 → $1.5
Current: $0.8687
Upside: +72.67%
Globus Medical
Nov 6, 2026
Reiterated: Buy
Price Target: $100
Current: $71.05
Upside: +40.75%
Shoulder Innovations
Nov 6, 2026
Reiterated: Buy
Price Target: $25
Current: $20.54
Upside: +21.71%
TransMedics Group
Nov 6, 2026
Reiterated: Buy
Price Target: $100
Current: $88.24
Upside: +13.33%
Tandem Diabetes Care
Nov 6, 2026
Reiterated: Buy
Price Target: $33
Current: $16.91
Upside: +95.15%
Sight Sciences
Nov 5, 2026
Reiterated: Buy
Price Target: $3.5 → $12
Current: $10.08
Upside: +19.05%
AtriCure
Nov 4, 2026
Reiterated: Buy
Price Target: $60 → $70
Current: $58.54
Upside: +19.58%
SI-BONE
Nov 3, 2026
Reiterated: Buy
Price Target: $25
Current: $24.24
Upside: +3.14%
Alphatec Holdings
Oct 30, 2026
Reiterated: Buy
Price Target: $14
Current: $7.44
Upside: +88.17%
DexCom
Oct 30, 2026
Reiterated: Buy
Price Target: $95
Current: $79.41
Upside: +19.63%
Oct 30, 2026
Reiterated: Buy
Price Target: $390 → $325
Current: $325.87
Upside: -0.27%
Oct 29, 2026
Reiterated: Hold
Price Target: $45
Current: $51.50
Upside: -12.62%
Oct 28, 2026
Reiterated: Buy
Price Target: $20 → $24
Current: $15.70
Upside: +52.87%
Oct 28, 2026
Reiterated: Buy
Price Target: $25 → $30
Current: $31.76
Upside: -5.54%
Oct 22, 2026
Reiterated: Hold
Price Target: $85
Current: $101.80
Upside: -16.50%
Oct 20, 2026
Reiterated: Buy
Price Target: $45 → $64
Current: $52.40
Upside: +22.14%
Oct 15, 2026
Reiterated: Buy
Price Target: $10 → $12
Current: $5.68
Upside: +111.27%
Oct 14, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $42.75
Upside: +40.35%
Oct 5, 2026
Reiterated: Buy
Price Target: $30
Current: $28.80
Upside: +4.17%
Aug 11, 2026
Reiterated: Hold
Price Target: $1
Current: $0.82
Upside: +21.95%
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $14.52
Upside: +23.97%
Aug 5, 2026
Reiterated: Buy
Price Target: $35 → $25
Current: $20.62
Upside: +21.24%
Aug 3, 2026
Downgraded: Hold
Price Target: $97 → $127
Current: $126.56
Upside: +0.35%
Jun 15, 2026
Reiterated: Buy
Price Target: $210
Current: $146.51
Upside: +43.33%
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $16.71
Upside: -4.25%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.0649
Upside: +4,522.50%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $319.21
Upside: +17.16%
Oct 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $105.59
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $16
Current: $25.21
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $150.87
Upside: n/a
Feb 14, 2025
Reiterated: Hold
Price Target: $12 → $11
Current: $16.59
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $140 → $180
Current: $224.41
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $2.93
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $0.4482
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $55 → $44
Current: $13.42
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $9 → $11
Current: $0.8374
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $10 → $90
Current: $0.0002
Upside: n/a
Nov 9, 2021
Reiterated: Buy
Price Target: $12 → $10
Current: $2.15
Upside: n/a
Sep 2, 2021
Reiterated: Hold
Price Target: $82
Current: $25.79
Upside: n/a
Jul 30, 2021
Reiterated: Buy
Price Target: $62 → $79
Current: $87.23
Upside: n/a
Jul 6, 2021
Reiterated: Buy
Price Target: $70
Current: $26.03
Upside: n/a
Mar 23, 2021
Reiterated: Hold
Price Target: $3.5
Current: $3.09
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $370 → $435
Current: $62.36
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $89.99
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jul 23, 2020
Reiterated: Buy
Price Target: $258 → $345
Current: $166.00
Upside: n/a
Sep 25, 2019
Reiterated: Buy
Price Target: $600 → $633
Current: $452.80
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $5.81
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $3.31
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $6.03
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $9.46
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $235.30
Upside: n/a
Aug 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $0.2894
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $8.04
Upside: n/a